STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 106 filers reported holding STOKE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,563 | -37.3% | 66 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $4,087 | +84.9% | 66 | 0.0% | 0.00% | – |
| Q3 2020 | $2,210 | +40.5% | 66 | 0.0% | 0.00% | – |
| Q2 2020 | $1,573 | -60.1% | 66 | -61.6% | 0.00% | -100.0% |
| Q1 2020 | $3,939 | -19.1% | 172 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $4,871 | – | 172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $1,062,825,000 | 82.06% |
| RTW INVESTMENTS, LP | 3,544,248 | $219,495,000 | 3.68% |
| Cormorant Asset Management, LP | 1,437,807 | $89,043,000 | 2.12% |
| Redmile Group, LLC | 2,686,234 | $166,358,000 | 2.01% |
| ACUTA CAPITAL PARTNERS, LLC | 92,500 | $5,729,000 | 1.56% |
| Pinz Capital Management, LP | 34,200 | $2,118,000 | 0.96% |
| Birchview Capital, LP | 20,000 | $1,239,000 | 0.71% |
| HighVista Strategies LLC | 17,668 | $1,094,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 1,470,841 | $91,089,000 | 0.45% |
| Perceptive Advisors | 671,978 | $41,616,000 | 0.45% |